Madagascar vs Philippines: Pneumococcal conjugate second or third-dose vaccines (PCVc) immunizati
Madagascar
56.0%
in 2025
Philippines
59.0%
in 2025
Madagascar rank
151st
Philippines rank
148th
Pneumococcal conjugate second or third-dose vaccines (PCVc) immunizati over time
- Madagascar
- Philippines
How they compare
Philippines currently reports 59.0% against 56.0% in Madagascar, a difference of 3.0%.
That makes Philippines's figure about 1.1 times Madagascar's.
The two have swapped places 4 times across 18 shared years of data; in 2008 it was Philippines ahead.
Madagascar ranks 151st and Philippines ranks 148th of 194 countries.
Across the 3 decades both report, Madagascar averaged higher in 1 and Philippines in 1.
Head to head by decade
| Decade | Madagascar | Philippines | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 0.0% | 0.0% | 0.0% | — |
| 2010s | 47.6% | 24.3% | 23.3% | Madagascar |
| 2020s | 60.7% | 70.2% | 9.5% | Philippines |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher pneumococcal conjugate second or third-dose vaccines (pcvc) immunizati, Madagascar or Philippines?
- Philippines, at 59.0% against 56.0% in Madagascar as of 2025.
- What is the difference in pneumococcal conjugate second or third-dose vaccines (pcvc) immunizati between Madagascar and Philippines?
- 3.0%, with Philippines ahead.
- How many years of comparable data are there for Madagascar and Philippines?
- 18 years are reported by both, from 2008 to 2025.
- How do Madagascar and Philippines rank globally for pneumococcal conjugate second or third-dose vaccines (pcvc) immunizati?
- Madagascar ranks 151st and Philippines ranks 148th of 194 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as Pneumococcal conjugate second or third-dose vaccines (PCVc) immunization coverage by the locally recommended age (%) (WUENIC). Statizoid refreshes it automatically from the source and publishes the full history for both places.